文献速递腹部介入CTDSA

部分脾动脉栓塞术后肝硬化伴脾功能亢进患者骨骼肌质量的变化

Change of skeletal muscle mass in cirrhotic patients with hypersplenism after partial splenic artery embolization.
PubMed 文献 · Eur J Radiol · 2024-09-25

本研究纳入105例肝硬化伴脾功能亢进患者,分析部分脾动脉栓塞术(PSAE)前后CT图像上的骨骼肌指数(SMI)变化。结果显示,在合并肌少症的患者中,PSAE术后12个月L3 SMI从36.77 cm²/m²升高至43.38 cm²/m²(P<0.01),L3皮下脂肪面积从79.16 cm²升高至103.52 cm²(P<0.01);无肌少症患者L3 SMI从58.38 cm²/m²降至49.44 cm²/m²(P<0.05)。脾梗死率和术前SMI是肌少症患者骨骼肌改善的独立预测因素。

要点

  • 肝硬化伴脾功能亢进患者中肌少症发生率为60.00%(63/105),男性占68.25%(43/63),女性占31.75%(20/63)。
  • 合并肌少症者PSAE术后12个月L3 SMI和L3 SFA均显著升高(P<0.01),无肌少症者L3 SMI显著降低(P<0.05)。
  • 脾梗死率(OR: 0.01, P=0.0032)和术前SMI(OR: 0.84, P<0.001)是肌少症患者骨骼肌改善的独立预测因素。

核心结论

  • 在合并肌少症的肝硬化伴脾功能亢进患者中,PSAE术后可观察到骨骼肌和脂肪质量改善;脾梗死率和术前L3 SMI可预测肌少症患者PSAE术后骨骼肌指数的改善。

研究设计与样本

  • 研究纳入2013年12月至2022年3月期间接受PSAE的466例肝硬化伴脾功能亢进患者,最终纳入105例进行分析,分析其医疗记录和CT图像。

关键影像表现/征象

  • 合并肌少症患者PSAE术后12个月L3 SMI从基线36.77 cm²/m²升高至43.38 cm²/m²(P<0.01)。
  • 合并肌少症患者PSAE术后12个月L3 SFA从基线79.16 cm²升高至103.52 cm²(P<0.01)。
  • 无肌少症患者PSAE术后12个月L3 SMI从基线58.38 cm²/m²降低至49.44 cm²/m²(P<0.05)。
  • 无肌少症患者PSAE术后12个月L3 SFA从基线89.63 cm²升高至94.77 cm²(P>0.05)。
  • 肝硬化患者整体PSAE术后L3平均SMI无显著变化。

诊断标准与关键数值

  • 肌少症在105例肝硬化伴脾功能亢进患者中占60.00%(63/105),其中男性43例(68.25%),女性20例(31.75%)。
  • 单因素和多因素分析显示脾梗死率(OR: 0.01, P=0.0032)和SMI(OR: 0.84, P<0.001)是肌少症患者骨骼肌改善的独立预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Partial splenic artery embolization (PSAE) is an effective procedure for cirrhotic patients with hypersplenism. The aim of our study is to evaluate the effect of PSAE on skeletal muscle, and to identify the predictor for an improvement in skeletal muscle index (SMI) in cirrhotic patients with hypersplenism after PSAE.

MATERIALS AND METHODS: 466 cirrhotic patients with hypersplenism underwent PASE between Dec 2013 and Mar 2022. Medical records and CT images of enrolled patients were analyzed.

RESULTS: 105 cirrhotic patients with hypersplenism were enrolled. Sarcopenia was observed in 60.00 % (63/105) of these patients, 68.25 % (43/63) of male patients, and 31.75 % (20/63) of female patients. In cirrhotic patients, no significant change in the mean SMI at the third lumbar vertebra (L3) level after PSAE. In patients with sarcopenia, the L3 SMI increased from 36.77 cm2/m2 (baseline) to 43.38 cm2/m2 (P < 0.01), the L3 subcutaneous fat area (SFA) increased from 79.16 cm2 (baseline) to 103.52 cm2 (P < 0.01) at 12-month follow-up after PSAE. In patients without sarcopenia, the L3 SMI decreased from 58.38 cm2/m2 (baseline) to 49.44 cm2/m2 (P < 0.05), the L3 SFA increased from 89.63 cm2 (baseline) to 94.77 cm2 (P > 0.05) at 12-month follow-up after PSAE. Univariate and multivariate analysis demonstrated splenic infarction rate (OR: 0.01, P = 0.0032) and SMI (OR: 0.84, P < 0.001) were independent predictors for an improvement in skeletal muscle in patients with sarcopenia.

CONCLUSIONS: In cirrhotic patients with sarcopenia, an improvement in skeletal muscle and fat mass was observed after PSAE; splenic infarction rate and the L3 SMI before PSAE predicted an improvement in skeletal muscle index in patients with sarcopenia after PSAE.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Gao H, Kan X, Li X, et al. Change of skeletal muscle mass in cirrhotic patients with hypersplenism after partial splenic artery embolization. Eur J Radiol. 2024. PMID: 39342883. doi:10.1016/j.ejrad.2024.111762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。